Analyzing...
Loading company...
No significant concerns identified
Nothing flagged for monitoring
“we are on track to deliver 15% the CACR 15% revenue growth and 20% PAT or EPS growth for next three to four years.”
“we are on track to deliver 15% the CACR 15% revenue growth and 20% PAT or EPS growth for next three to four years.”
“grow on 15% on revenue”
Historical valuation data not available.
Revenue segment breakdown not available.
No related party data available for this company.
This section will be populated when data becomes available.
CORONA Remedies Limited has informed the Exchange about Copy of Newspaper Publication - Notice of 22nd Annual General Meeting, Intimation of Record date and E-votingInformation
CORONA Remedies Limited has informed the Exchange about Schedule of Analysts / Investor Conference
Dr. Kirtikumar L. Mehta has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regula...
CORONA Remedies Limited has informed the Exchange about Intimation of Non-Deal Roadshow
CORONA Remedies Limited has informed the Exchange about Intimation for Non-Deal Roadshow
CORONA Remedies Limited has informed the Exchange regarding a press release dated May 28, 2026, titled "Press Release - Receipt of EU-GMP Certificate".
CORONA Remedies Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regula...
Ankur K. Mehta has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 20...
CORONA Remedies Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regula...
CORONA Remedies Limited has informed the Exchange regarding 'Communication to Shareholders - Intimation on Tax Deduction on Dividend'.
CORONA Remedies Limited has informed the Exchange about Schedule of meet
CORONA Remedies Limited has informed the Exchange regarding 'Annual Secretarial Compliance Report for the year ended March 31, 2026'.
CORONA Remedies Limited has informed the Exchange about Link of Recording
CORONA Remedies Limited has informed the Exchange about copy of newspaper publication of Audited Financial Results for the fourth quarter and year ended on March 31, 2026
CORONA Remedies Limited has informed the Exchange about Schedule of meet
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.